Circulating pregnancy-associated plasma protein A is not an early marker of acute myocardial infarction

Objective: The purpose of this study was to assess whether serum levels of pregnancy-associated plasma protein A (PAPP-A) are elevated early in patients with acute myocardial infarction (AMI). Design and methods: We measured serum levels of PAPP-A in 80 patients with AMI and in 80 age-matched healthy control subjects. The mean (±SEM) time from onset of symptoms to blood sampling was 6.3 ± 2.8 h in the group with AMI. Results: The PAPP-A levels did not differ between the control group and the AMI group (1.24 ± 0.07 vs. 1.29 ± 0.02 mIU/l; P = 0.54). Conclusions: Measurement of serum PAPP-A does not seem to be a useful early marker for AMI.